| Chr | chr21 |
| start | 40383083 |
| end | 40385358 |
| lncRNA name | DSCAM-AS1 |
| entrez id | 100506492 |
| hgnc id | HGNC:40197 |
| ensg id | ENSG00000235123 |
| refseq id | NR_038896 |
| methods | RNA-seq, qPCR, RNAi, RIP, ChIP, Cell proliferation assay etc. |
| regulated | up-regulated |
| function description | Among the luminal breast cancers, DSCAM-AS1 is expressed significantly higher in luminal B, a clinical subtype containing most of the clinically aggressive ER-positive breast cancers. We demonstrate that DSCAM-AS1 mediates tumour progression and tamoxifen resistance and identify hnRNPL as an interacting protein involved in the mechanism of DSCAM-AS1 action. |
| pubmed id | 27666543 |
| year | 2016 |
| title | The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. |
| drug | V |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China